Our Alzheimer's research achieved an important breakthrough, with two significant studies published this October. On October 17 , we announced the results of a new study using our DIFS technology, ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

A breakthrough AI model analyzes diverse data to reveal faster Alzheimer’s progression in Black females ... uncovering ...

A team of researchers at Kumamoto University has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease ...

An Alzheimer's treatment, lecanemab, was found to triple the risk of death within a year, compared with dementia sufferers ...

The human brain's glymphatic system, instrumental in removing toxins, has been visualized in living people through MRI ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

Covering prominent disease areas like lung cancer and Alzheimer’s Disease, as well as conditions scientists are only starting to understand, such as Relative Energy Deficiency in Sport (REDs), these ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...